Aarti Drugs (AARTIDRUGS)

STALWART

FairStock Score: 35/100 — MIXED

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Current Price₹372
Market Cap₹3,349.61 Cr
P/E Ratio16.53
ROCE13.09%
ROE16.02%
Dividend Yield0.54%
Profit Growth9.42%
Debt/Equity0.39
Sales Growth8.1%
Promoter Holding55.03%
52-Week Range₹318.95 — ₹564.05
SectorPharmaceuticals & Biotechnology
Book Value₹127.49

Aarti Drugs trades with a P/E ratio of 16.53, ROCE of 13.09%, ROE of 16.02%, profit growth of 9.42%, debt-to-equity of 0.39. The FairStock Score of 35/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer